Zolamide sodium | CAS# 72296-05-0 | Biochemical

MedKoo Cat#: 573869 | Name: Zolamide sodium

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Zolamide sodium may be used to prevent and reduce the symptoms of altitude sickness. This drug is also used with other medications to treat open-angle glaucoma due to its efficacy as a diuretic. It decreases the amount of fluid that can build up in the eye. It is also used to decrease a buildup of body fluids (edema) caused by congestive heart failure or certain medications. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures).

Chemical Structure

Zolamide sodium

CAS#72296-05-0

Theoretical Analysis

MedKoo Cat#: 573869

Name: Zolamide sodium

CAS#: 72296-05-0

Chemical Formula: C2H3N4NaO2S2

Exact Mass: 201.9595

Molecular Weight: 202.18

Elemental Analysis: C, 11.88; H, 1.50; N, 27.71; Na, 11.37; O, 15.83; S, 31.71

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

14949-00-9 (free base)

Synonym

Amino thiadiazole sulfonamide, CL 5343 sodium salt, Tio-urasin sodium, Zolamide sodium

IUPAC/Chemical Name

1,3,4-Thiadiazole-2-sulfonamide, 5-amino-, monosodium salt

InChi Key

QSGOFQPIEHAARI-UHFFFAOYSA-N

InChi Code

1S/C2H3N4O2S2.Na/c3-1-5-6-2(9-1)10(4,7)8;/h(H3-,3,4,5,7,8);/q-1;+1

SMILES Code

c1(nnc(s1)S(=O)(=O)[NH-])N.[Na+]

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 202.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Van Berkel MA, Elefritz JL. Evaluating off-label uses of acetazolamide. Am J Health Syst Pharm. 2018 Apr 15;75(8):524-531. doi: 10.2146/ajhp170279. Review. PubMed PMID: 29626002. 2: Arenas-García JI, Herrera-Ruiz D, Morales-Rojas H, Höpfl H. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. Eur J Pharm Sci. 2017 Jan 1;96:299-308. doi: 10.1016/j.ejps.2016.09.025. Epub 2016 Sep 17. PubMed PMID: 27650458. 3: Llovet-Rausell A, Ruiz Tolosa F, Kudsieh B. Severe ocular side effects with acetazolamide: case report. Arch Soc Esp Oftalmol. 2016 Nov;91(11):543-546. doi: 10.1016/j.oftal.2016.03.013. Epub 2016 May 11. English, Spanish. PubMed PMID: 27179669. 4: Al-Saleem AI, Al-Jobair AM. Possible association between acetazolamide administration during pregnancy and multiple congenital malformations. Drug Des Devel Ther. 2016 Apr 15;10:1471-6. doi: 10.2147/DDDT.S99561. eCollection 2016. PubMed PMID: 27143854; PubMed Central PMCID: PMC4841426. 5: Santoveña A, Suárez-González J, Martín-Rodríguez C, Fariña JB. Formulation design of oral pediatric Acetazolamide suspension: dose uniformity and physico-chemical stability study. Pharm Dev Technol. 2017 Mar;22(2):191-197. doi: 10.1080/10837450.2016.1175475. Epub 2016 Apr 24. PubMed PMID: 27109383. 6: Biondich AS, Joslin JD. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS. Wilderness Environ Med. 2016 Mar;27(1):179-80. doi: 10.1016/j.wem.2015.09.001. Epub 2015 Oct 29. PubMed PMID: 26520404. 7: Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother. 2015;15(8):851-6. doi: 10.1586/14737175.2015.1066675. Epub 2015 Jul 7. Review. PubMed PMID: 26154918. 8: Falardeau J, Lobb BM, Golden S, Maxfield SD, Tanne E. The use of acetazolamide during pregnancy in intracranial hypertension patients. J Neuroophthalmol. 2013 Mar;33(1):9-12. doi: 10.1097/WNO.0b013e3182594001. PubMed PMID: 22635167. 9: Kassamali R, Sica DA. Acetazolamide: a forgotten diuretic agent. Cardiol Rev. 2011 Nov-Dec;19(6):276-8. doi: 10.1097/CRD.0b013e31822b4939. Review. PubMed PMID: 21983315. 10: Reiss WG, Oles KS. Acetazolamide in the treatment of seizures. Ann Pharmacother. 1996 May;30(5):514-9. Review. PubMed PMID: 8740334.